Stockscreener 앱 받기
2.72
3.20%
-0.09
시장 영업 전:
2.78
0.06
+2.21%
Taysha Gene Therapies Inc 주식(TSHA)의 최신 뉴스
Wells Fargo Remains Bullish on Taysha Gene Therapies (TSHA) - MSN
Earnings Preview: TSHA to Report Financial Results Pre-market on August 12 - 富途牛牛
Taysha Gene Therapies to Release Second Quarter 2025 Financial Results and Host Conference Call and Webcast on August 12 - The Manila Times
Taysha Gene Therapies to Release Second Quarter 2025 - GlobeNewswire
Will Taysha Gene Therapies, Inc. (TSHA) Report Negative Q2 Earnings? What You Should Know - Yahoo Finance
RSI Crosses Above 30 for Taysha Gene Therapies Inc. — Reversal in SightCommunity Shared Smart Money Signals Show Movement - beatles.ru
What are analysts’ price targets for Taysha Gene Therapies Inc. in the next 12 monthsDiscover undervalued stocks before they soar - Jammu Links News
What are Taysha Gene Therapies Inc. company’s key revenue driversBuild wealth with steady, reliable stocks - Jammu Links News
How many analysts rate Taysha Gene Therapies Inc. as a “Buy”Maximize gains with data-driven stock picks - Jammu Links News
What analysts say about Taysha Gene Therapies Inc. stockSuperior trading gains - Jammu Links News
10 Best Strong Buy Penny Stocks to Buy Now - Insider Monkey
What is Taysha Gene Therapies Inc. company’s growth strategyTriple returns potential - Jammu Links News
Is Taysha Gene Therapies Inc. stock overvalued or undervaluedUnlock real-time stock alerts for quick profits - Jammu Links News
How does Taysha Gene Therapies Inc. generate profit in a changing economyFree Trend-Following Techniques - Jammu Links News
What are the latest earnings results for Taysha Gene Therapies Inc.Maximize returns with strategic trading plans - Jammu Links News
What are the technical indicators suggesting about Taysha Gene Therapies Inc.Achieve triple-digit returns with smart investing - Jammu Links News
What makes Taysha Gene Therapies Inc. stock price move sharplyAchieve breakthrough financial growth - jammulinksnews.com
Taysha Gene Therapies Announces New Employee Stock Option Grant Under Nasdaq Listing Rule 5635(c)(4) - AInvest
Taysha Gene Therapies (TSHA) Moves to Buy: Rationale Behind the Upgrade - MSN
What is the risk reward ratio of investing in Taysha Gene Therapies Inc. stockDaily Trading Opportunities For Fast Growth - Jammu Links News
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Taysha Gene Therapies Offers $236,700 Stock Option Package to Strategic New Hire - Stock Titan
Fibonacci Retracement Aligns with Support in Taysha Gene Therapies Inc.Quick Gain Stock Watch With Indicators Reviewed - metal.it
BofA Securities Affirms ‘Buy’ Rating on Taysha Gene Therapies (TSHA) on TSHA-102 Prospects - MSN
Needham Maintains a Buy on Taysha Gene Therapies (TSHA), Keeps PT at $8 - Insider Monkey
14 Best Biotech Penny Stocks to Buy Right Now - Insider Monkey
10 Penny Stocks That Will Skyrocket - Insider Monkey
Will Taysha Gene Therapies Inc. stock benefit from AI tech trendsFree Smart Money Stock Analysis - beatles.ru
How did TSHA's Q1 2024 EPS surprise impact short-term traders? - AInvest
What institutional investors are buying Taysha Gene Therapies Inc. stockExponential return rates - Jammu Links News
Is it the right time to buy Taysha Gene Therapies Inc. stockMaximize your gains with professional insights - Jammu Links News
Why is Taysha Gene Therapies Inc. stock attracting strong analyst attentionCapitalize on fast-moving market trends - Jammu Links News
Certain Options of Taysha Gene Therapies, Inc. are subject to a Lock-Up Agreement Ending on 28-JUL-2025. - MarketScreener
How Taysha Gene Therapies Inc. stock performs during market volatility200 Percent Profit Outlook - metal.it
Taysha Gene Therapies Inc. Stock Analysis and ForecastConsistently superior profits - PrintWeekIndia
Is Taysha Gene Therapies Inc. a good long term investmentLightning-fast growth - PrintWeekIndia
Can Taysha Gene Therapies Inc. stock recover from recent declineConsistently profitable trades - Jammu Links News
Rett bet set includes Neurogene, Taysha gene therapies - BioWorld MedTech
What drives Taysha Gene Therapies Inc. stock priceUnrivaled growth potential - Autocar Professional
0.24%
3.39%
자본화:
|
볼륨(24시간):